C32H45N3O5S
Neat
583.80
-20°C
Room Temperature
Nelfinavir Hydroxy-tert-butylamide; 213135-56-9; (3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-N-(1-hydroxy-2-methylpropan-2-yl)-3, 4, 4a, 5, 6, 7, 8, 8a-octahydro-1H-isoquinoline-3-carboxamide; (3S, 4aS, 8aS)-N-(2-hydroxy-1, 1-dimethyl-ethyl)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3, 4, 4a, 5, 6, 7, 8, 8a-octahydro-1H-isoquinoline-3-carboxamide; Nelfinavir deriv.; AG 1402; 8SJ9CB28K9; C32H45N3O5S; FN26177; (3S, 4aS, 8aS)-Decahydro-N-(2-hydroxy-1, 1-dimethylethyl)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide; M 8; NS00116198; (3S, 4aS, 8aS)-Decahydro-N-(2-hydroxy-1, 1-dimethylethyl)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl ]-3-isoquinolinecarboxamide; (3S, 4AS, 8aS)-N-(1-hydroxy-2-methylpropan-2-yl)-2-((2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide; [3S-[2(2S*, 3S*), 3.alpha., 4a.beta., 8a.beta., ]]-N-(1, 1-Dimethyl-2-hydroxyethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-3-isoquinolinecarboxamide; 3-Isoquinolinecarboxamide, decahydro-N-(2-hydroxy-1, 1-dimethylethyl)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S, 4aS and 8aS)
(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-N-(1-hydroxy-2-methylpropan-2-yl)-3, 4, 4a, 5, 6, 7, 8 and 8a-octahydro-1H-isoquinoline-3-carboxamide
InChI=1S/C32H45N3O5S/c1-21-25(14-9-15-28(21)37)30(39)33-26(19-41-24-12-5-4-6-13-24)29(38)18-35-17-23-11-8-7-10-22(23)16-27(35)31(40)34-32(2,3)20-36/h4-6,9,12-15,22-23,26-27,29,36-38H,7-8,10-11,16-20H2,1-3H3,(H,33,39)(H,34,40)/t22-,23+,26-,27-,29+/m0/s1